asa guidelines for glp-1 How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the and Decoding the Enigma: Strategies Anesthetic Management of Patients on Glucagon-Like Glucagon-Like Peptide-1 Agonists and General

GLP-1 receptor signaling contributes to anorexigenic effect of centrally administered oxytocin in rats

Autoimmune thyroid disease frequently coexists with metabolic syndrome, a cluster of conditions including obesity, insulin resistance, dyslipidemia, and fatty liver disease

It is not intended for human or veterinary use and must not be applied in any way that contravenes MHRA regulations or other relevant laws

GLP-1 receptor activation primarily promotes glucose utilization and glycogen storage while reducing hepatic glucose production

While convenient, storing peptides in plastic syringes for extended periods can lead to adsorption (where the peptide sticks to the plastic) and potential degradation

Past allergic reactions to GLP-1 drugs might also pose a problem